Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Ceftolozaan-tazobactam versus meropenem bij nosocomiale pneumonie
feb 2020 | Bacteriële infecties, Pneumonie